SERACARE LIFE SCIENCES INC has a total of 29 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology and measurement are CENTRAL MANCHESTER HEALTHCARE, 302 MILITARY OF CHINA and NIPPON GENE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 4 | |
#5 | Canada | 4 | |
#6 | Israel | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Anekella Bharathi | 20 |
#2 | Huang Catherine | 20 |
#3 | Konigshofer Yves | 10 |
#4 | Garlick Russell | 8 |
#5 | Tomson Farol | 5 |
#6 | Harkins Seth | 5 |
#7 | Nguyen Lequan T | 5 |
#8 | Ku Alice | 5 |
#9 | Li Jonathan | 3 |
Publication | Filing date | Title |
---|---|---|
US2018142299A1 | Methods for preparing dna reference materials and controls | |
US2019177794A1 | Multiplex cellular reference materials | |
WO2017074517A1 | Adenovirus control virus | |
EP3310368A1 | Sindbis control virus | |
CA2985135A1 | Liposomal preparations for non-invasive-prenatal or cancer screening |